Pfizer Reviews German Investment Plans Amid Healthcare Cost-Control Proposals
Pfizer is reassessing planned investments in Germany after proposed healthcare reforms raised concerns within the pharmaceutical industry about the future attractiveness of Europe's largest healthcare market.